Synthetic Biologics, Inc.
Synthetic Biologics, Inc. (SYN) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 24 transactions totaling $18.6M, demonstrating a bullish sentiment with $2.6M in net insider flow. The most recent transaction on May 10, 2021 involved a purchase of 50,000 shares valued at $24.5K.
SYN Insider Activity Summary
Who Is Buying SYN Stock?
No significant insider buying has been recorded for SYN in the recent period.
Who Is Selling SYN Stock?
No significant insider selling has been recorded for SYN in the recent period.
Is Synthetic Biologics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SYN is bullish with an Insider Alignment Score of 57/100 and a net flow of $2.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SYN Frequently Asked Questions
Understanding SYN Insider Activity
Insider trading at Synthetic Biologics, Inc. (SYN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading SYN stock, having executed 24 transactions in the past 90 days. The most active insider is Randal J. Kirk (Executive), who has made 2 transactions totaling $8.0M.
Related Tools
Track Synthetic Biologics, Inc. Insider Activity
Get notified when executives and directors at SYN file new Form 4 transactions